Concepedia

Matthew R. Collinson-Pautz

MR

Statistics

Publications

6

Citations

482

H-Index

6

Active since

2010

Affiliations

Bellicum Pharmaceuticals (United States)(Current)

Baylor College of Medicine

Matthew R. Collinson-Pautz is an author at Bellicum Pharmaceuticals (United States) specializing in life sciences, immunology, and t cell activation.

ORCID

Publications per year

2010–2023

6

Publications

6

Rotavirus Disrupts Calcium Homeostasis by NSP4 Viroporin Activity

Joseph M. Hyser, Matthew R. Collinson-Pautz, Budi Utama et al. · mBio · 2010 · 158 citations · Full text

, , +17

Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40

Aaron E. Foster, Aruna Mahendravada, Nicholas Shinners et al. · Molecular Therapy · 2017 · 106 citations · Full text

, , +17

Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal Switches

MyLinh T. Duong, Matthew R. Collinson-Pautz, Éva Morschl et al. · Molecular Therapy — Oncolytics · 2018 · 83 citations · Full text

, , +17

Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies

Matthew R. Collinson-Pautz, Wei-Chun Chang, An Lu et al. · Leukemia · 2019 · 80 citations · Full text

, , +17

Tobacco mosaic virus efficiently targets DC uptake, activation and antigen-specific T cell responses in vivo

Jan O. Kemnade, Mamatha Seethammagari, Matthew R. Collinson-Pautz et al. · Vaccine · 2014 · 43 citations

, , +13

1–5 of 6